May 2023 / INVESTMENT INSIGHTS
Medical Technology Industry Well Positioned Post-COVID
Many businesses in the health care sector can consistently grow revenue and earnings, even in difficult macroeconomic times.
Key Insights
- Many businesses in the health care sector can consistently grow revenue and earnings, even in challenging macroeconomic environments.
- The medical technology, or medtech, industry is one area of health care that we believe is particularly well positioned for the near term.
- We prefer health care firms with high recurring revenues from consumables and services as opposed to those that are reliant on sales of capital equipment.
IMPORTANT INFORMATION
Where securities are mentioned, the specific securities identified and described are for informational purposes only and do not represent recommendations.
This material is being furnished for general informational purposes only. The material does not constitute or undertake to give advice of any nature, including fiduciary investment advice, nor is it intended to serve as the primary basis for an investment decision. Prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a reliable indicator of future performance. Investment involves risks. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested.
The material does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. The material has not been reviewed by any regulatory authority in any jurisdiction.
Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources' accuracy or completeness. There is no guarantee that any forecasts made will come to pass. The views contained herein are as of the date noted on the material and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price.
The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request.
Mitch Unger is a corporate credit analyst in the Fixed Income Division. He is a vice president and member of the Investment Advisory Committee of the Corporate Income Fund. He also is a member of the Money Market Credit Policy Committee. Mitch is a vice president of T. Rowe Price Group, Inc., and T. Rowe Price Associates, Inc.